Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 150 publications
Zanubrutinib versus fludarabine, cyclophosphamide and rituximab in fit, treatment-naïve patients with chronic lymphocytic leukemia: a matching-adjusted indirect comparison.
Journal: Journal of comparative effectiveness research
Published: August 21, 2026
Comparative efficacy of tislelizumab + FOLFOX or CAPOX for gastric/gastroesophageal junction adenocarcinoma: an exploratory matching-adjusted indirect comparison.
Journal: Current medical research and opinion
Published: June 29, 2026
Clinical benefit of PD-1 antibody plus chemotherapy in advanced HER2 negative gastric or gastro-oesophageal junction adenocarcinoma according to PD-L1 levels: Post-hoc analysis of RATIONALE-305 and pooled analysis of individual patient-level data.
Journal: Journal of hematology & oncology
Published: April 26, 2026
Effects of Pore Structure on Methane Adsorption and Diffusion Properties in Varying-Rank Coals Modified by Tetrahydrofuran.
Journal: Langmuir : the ACS journal of surfaces and colloids
Published: April 07, 2026
Indirect Comparison of the Efficacy of Zanubrutinib vs Ibrutinib and Acalabrutinib in Treatment-Naive Chronic Lymphocytic Leukemia: 6-Year Follow-Up.
Journal: Advances in therapy
Published: April 01, 2026
Emerging Approaches for the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease: The Application of Nanomedicines.
Journal: International journal of nanomedicine
Published: February 15, 2026
Medium- and Long-term CO2 Emission Projections and Emission Reduction Pathways in China： Application of the LEAP Model
Journal: Huan jing ke xue= Huanjing kexue
Published: February 09, 2026
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma, with or without peritoneal metastases: a post-hoc analysis on RATIONALE-305 study.
Journal: EClinicalMedicine
Published: January 22, 2026
Prolonged progression-free survival with zanubrutinib in relapsed/refractory CLL: an indirect treatment comparison versus other BTK inhibitors using multilevel network meta-regression.
Journal: Journal of medical economics
Published: January 19, 2026
GAS6 potentiates tumor progression through modulating suppressive microenvironments.
Journal: American journal of cancer research
Published: January 14, 2026
Timing impact of single shot femoral nerve block on rebound pain in patients undergoing total knee arthroplasty: a prospective randomized controlled trial.
Journal: Frontiers in medicine
Published: January 14, 2026
Simulation Study on the Wettability of Solutions and Coal under the Synergistic Effects of Magnetic Fields and Inorganic Salts.
Journal: Langmuir : the ACS journal of surfaces and colloids
Published: January 12, 2026
Last Updated: 09/26/2026